| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.53B | -0.7% |
| Cost of Revenue | $11.54B | -12.9% |
| Gross Profit | $5.99B | +35.6% |
| R&D Expense | $2.14B | +52.6% |
| SG&A Expense | $1.69B | +71.5% |
| Operating Income | -$624.5M | -487.6% |
| Pre-tax Income | -$565.3M | -459.0% |
| Income Tax | -$12.3M | -802.6% |
| Net Income | -$540.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.54B | +2.3% |
| Accounts Receivable | $140.5M | +56.6% |
| Inventory | $97.7M | +26.8% |
| Current Assets | $15.62B | +48.5% |
| Total Assets | $31.36B | +125.2% |
| Current Liabilities | $8.43B | +55.2% |
| Long-term Debt | $4.11B | -9.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $175.9M | -79.3% |
| Capital Expenditures | $170.8M | +27.2% |
| Investing Cash Flow | $1.23B | +193.5% |
| Financing Cash Flow | $97.6M | -96.3% |
| Free Cash Flow | $5.1M | -99.3% |
| -425.2% |
| EPS (Basic) | -$0.93 | -358.3% |
| EPS (Diluted) | -$0.93 | -381.8% |
| Total Liabilities |
| $14.11B |
| +33.0% |
| Stockholders' Equity | $17.22B | +426.2% |